January 2025
- An Attribution of Value Framework for Combination Treatments
- Unpaid Caring and Health-Related Quality of Life: Longitudinal Analysis of Understanding Society (the UK Household Longitudinal Survey)
- A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines
- Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data: A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice
- Development of a Health-State Classification System for the Pediatric Quality-of-Life Inventory Version 4.0 Generic Core Scales for Preference-Based Valuation in Australia
February 2025
- Measurement Equivalence of Standard and Zoom-Enabled Electronic Clinical Outcome Assessments: Implications for Patient Accessibility in Clinical Trials
- Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report
- Value Framework Based on Multiple-Criteria Decision Analysis for Assessment of New Health Technologies Under Universal Healthcare Coverage System in Taiwan
- Healthcare Costs in the United States by Demographic Characteristics and Comorbidity Status
- Modeling the Potential Health, Health Economic, and Health Inequality Impact of a Large-Scale Rollout of the Drink Less App in England
March 2025
- Maternal Mental Health Spillovers From Child Illness and Disability: A Dynamic Panel Analysis
- Prevalence of Immature Survival Data for Anticancer Drugs Presented to the National Institute for Health and Care Excellence Between 2018 and 2022
- Economic Evaluation of 9 Intersectoral Strategies to Improve Youth Mental Health and Alleviate Financial Burden in Colombia Using System Dynamics Modeling
- The Psychometric Properties of the EQ-HWB and EQ-HWB-S in Patients With Breast Cancer: A Comparative Analysis With EQ-5D-5L, FACT-8D, and SWEMWBS
- Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis
April 2025
- How Do Bundled Payment Initiatives Account for Differences in Patient Risk Profiles? A Systematic Review
- Role of Health Equity in Health Technology Assessment Processes: A Landscape Analysis of 13 Health Systems in Asia
- IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease
- Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia
May 2025
- Public Health Supports Whole Health
- Taking Health Economics and Outcomes Research Forward: Expanding the Definition of Value to Include Whole Health
- Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products
- The Price Effects of Biosimilars in the United States
- Whole Health: A Global Perspective
- A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review
June 2025
- Quantifying Low-Value Care in Germany: An Observational Study Using Statutory Health Insurance Data From 2018 to 2021
- Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report
- Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies
- The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level
July 2025
- The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care
- Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions
- Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy
- Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review
August 2025
- Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study
- The Increasing Use of Clinical Outcome Assessments in US Food and Drug Administration Labels and the German Gemeinsamer Bundesausschuss, National Institute for Health and Care Excellence, and the French Haute Autorité de Santé Assessments F ...
- A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review
- Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity
- Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports
September 2025
- Validity and Reliability of the EQ-HWB in Parents of Children With Health Conditions
- Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe
- Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study
- Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies
- Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations